Lv4
452 积分 2025-04-07 加入
Semaglutide and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials
20天前
已完结
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DAPA-AFIB Randomized Trial
20天前
已关闭
Letter by Xu et al Regarding Article, “Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial”
20天前
已完结
Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study
20天前
已完结
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
20天前
已完结
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
20天前
已完结
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
20天前
已完结
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
20天前
已完结
Letter by Chen et al Regarding Article, "Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial"
20天前
已完结
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
20天前
已完结
皖公网安备34019202002308
